1 Lithium Therapy Market Overview

• 1.1 Product Overview and Scope of Lithium Therapy
• 1.2 Lithium Therapy Segment by Type
• 1.2.1 Global Lithium Therapy Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Capsule

1.2.3 Solution

1.2.4 Tablet

1.2.5 Others

1.3 Lithium Therapy Segment by Application

1.3.1 Global Lithium Therapy Sales Comparison by Application: (2022-2028)

1.3.2 Online Sales

1.3.3 Offline Sales

1.4 Global Lithium Therapy Market Size Estimates and Forecasts

1.4.1 Global Lithium Therapy Revenue 2017-2028

1.4.2 Global Lithium Therapy Sales 2017-2028

1.4.3 Lithium Therapy Market Size by Region: 2017 Versus 2021 Versus 2028

2 Lithium Therapy Market Competition by Manufacturers

• 2.1 Global Lithium Therapy Sales Market Share by Manufacturers (2017-2022)
• 2.2 Global Lithium Therapy Revenue Market Share by Manufacturers (2017-2022)
• 2.3 Global Lithium Therapy Average Price by Manufacturers (2017-2022)
• 2.4 Manufacturers Lithium Therapy Manufacturing Sites, Area Served, Product Type
• 2.5 Lithium Therapy Market Competitive Situation and Trends
• 2.5.1 Lithium Therapy Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Lithium Therapy Players Market Share by Revenue

2.5.3 Global Lithium Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Lithium Therapy Retrospective Market Scenario by Region

• 3.1 Global Lithium Therapy Retrospective Market Scenario in Sales by Region: 2017-2022
• 3.2 Global Lithium Therapy Retrospective Market Scenario in Revenue by Region: 2017-2022
• 3.3 North America Lithium Therapy Market Facts & Figures by Country
• 3.3.1 North America Lithium Therapy Sales by Country

3.3.2 North America Lithium Therapy Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Lithium Therapy Market Facts & Figures by Country

3.4.1 Europe Lithium Therapy Sales by Country

3.4.2 Europe Lithium Therapy Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Lithium Therapy Market Facts & Figures by Region

3.5.1 Asia Pacific Lithium Therapy Sales by Region

3.5.2 Asia Pacific Lithium Therapy Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Lithium Therapy Market Facts & Figures by Country

3.6.1 Latin America Lithium Therapy Sales by Country

3.6.2 Latin America Lithium Therapy Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Lithium Therapy Market Facts & Figures by Country

3.7.1 Middle East and Africa Lithium Therapy Sales by Country

3.7.2 Middle East and Africa Lithium Therapy Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Lithium Therapy Historic Market Analysis by Type

• 4.1 Global Lithium Therapy Sales Market Share by Type (2017-2022)
• 4.2 Global Lithium Therapy Revenue Market Share by Type (2017-2022)
• 4.3 Global Lithium Therapy Price by Type (2017-2022)

5 Global Lithium Therapy Historic Market Analysis by Application

• 5.1 Global Lithium Therapy Sales Market Share by Application (2017-2022)
• 5.2 Global Lithium Therapy Revenue Market Share by Application (2017-2022)
• 5.3 Global Lithium Therapy Price by Application (2017-2022)

6 Key Companies Profiled

• 6.1 Bristol-Myers Squibb
• 6.1.1 Bristol-Myers Squibb Corporation Information

6.1.2 Bristol-Myers Squibb Description and Business Overview

6.1.3 Bristol-Myers Squibb Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Bristol-Myers Squibb Lithium Therapy Product Portfolio

6.1.5 Bristol-Myers Squibb Recent Developments/Updates

6.2 Intellipharmaceutics

6.2.1 Intellipharmaceutics Corporation Information

6.2.2 Intellipharmaceutics Description and Business Overview

6.2.3 Intellipharmaceutics Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Intellipharmaceutics Lithium Therapy Product Portfolio

6.2.5 Intellipharmaceutics Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Pfizer Lithium Therapy Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Eli Lilly

6.4.1 Eli Lilly Corporation Information

6.4.2 Eli Lilly Description and Business Overview

6.4.3 Eli Lilly Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Eli Lilly Lithium Therapy Product Portfolio

6.4.5 Eli Lilly Recent Developments/Updates

6.5 Astrazeneca

6.5.1 Astrazeneca Corporation Information

6.5.2 Astrazeneca Description and Business Overview

6.5.3 Astrazeneca Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Astrazeneca Lithium Therapy Product Portfolio

6.5.5 Astrazeneca Recent Developments/Updates

6.6 GlaxoSmithKline

6.6.1 GlaxoSmithKline Corporation Information

6.6.2 GlaxoSmithKline Description and Business Overview

6.6.3 GlaxoSmithKline Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.6.4 GlaxoSmithKline Lithium Therapy Product Portfolio

6.6.5 GlaxoSmithKline Recent Developments/Updates

6.7 Lundbeck

6.6.1 Lundbeck Corporation Information

6.6.2 Lundbeck Description and Business Overview

6.6.3 Lundbeck Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Lundbeck Lithium Therapy Product Portfolio

6.7.5 Lundbeck Recent Developments/Updates

6.8 Allergan

6.8.1 Allergan Corporation Information

6.8.2 Allergan Description and Business Overview

6.8.3 Allergan Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Allergan Lithium Therapy Product Portfolio

6.8.5 Allergan Recent Developments/Updates

6.9 Otsuka Pharmaceutical

6.9.1 Otsuka Pharmaceutical Corporation Information

6.9.2 Otsuka Pharmaceutical Description and Business Overview

6.9.3 Otsuka Pharmaceutical Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Otsuka Pharmaceutical Lithium Therapy Product Portfolio

6.9.5 Otsuka Pharmaceutical Recent Developments/Updates

6.10 Takeda

6.10.1 Takeda Corporation Information

6.10.2 Takeda Description and Business Overview

6.10.3 Takeda Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Takeda Lithium Therapy Product Portfolio

6.10.5 Takeda Recent Developments/Updates

6.11 NHU Group

6.11.1 NHU Group Corporation Information

6.11.2 NHU Group Lithium Therapy Description and Business Overview

6.11.3 NHU Group Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.11.4 NHU Group Lithium Therapy Product Portfolio

6.11.5 NHU Group Recent Developments/Updates

6.12 Shionogi

6.12.1 Shionogi Corporation Information

6.12.2 Shionogi Lithium Therapy Description and Business Overview

6.12.3 Shionogi Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Shionogi Lithium Therapy Product Portfolio

6.12.5 Shionogi Recent Developments/Updates

6.13 APOTEX

6.13.1 APOTEX Corporation Information

6.13.2 APOTEX Lithium Therapy Description and Business Overview

6.13.3 APOTEX Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.13.4 APOTEX Lithium Therapy Product Portfolio

6.13.5 APOTEX Recent Developments/Updates

6.14 Kanghong Pharma

6.14.1 Kanghong Pharma Corporation Information

6.14.2 Kanghong Pharma Lithium Therapy Description and Business Overview

6.14.3 Kanghong Pharma Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Kanghong Pharma Lithium Therapy Product Portfolio

6.14.5 Kanghong Pharma Recent Developments/Updates

6.15 HUAHAI

6.15.1 HUAHAI Corporation Information

6.15.2 HUAHAI Lithium Therapy Description and Business Overview

6.15.3 HUAHAI Lithium Therapy Sales, Revenue and Gross Margin (2017-2022)

6.15.4 HUAHAI Lithium Therapy Product Portfolio

6.15.5 HUAHAI Recent Developments/Updates

7 Lithium Therapy Manufacturing Cost Analysis

• 7.1 Lithium Therapy Key Raw Materials Analysis
• 7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Lithium Therapy

7.4 Lithium Therapy Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Lithium Therapy Distributors List
• 8.3 Lithium Therapy Customers

9 Lithium Therapy Market Dynamics

• 9.1 Lithium Therapy Industry Trends
• 9.2 Lithium Therapy Market Drivers
• 9.3 Lithium Therapy Market Challenges
• 9.4 Lithium Therapy Market Restraints

10 Global Market Forecast

• 10.1 Lithium Therapy Market Estimates and Projections by Type
• 10.1.1 Global Forecasted Sales of Lithium Therapy by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Lithium Therapy by Type (2023-2028)

10.2 Lithium Therapy Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Lithium Therapy by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Lithium Therapy by Application (2023-2028)

10.3 Lithium Therapy Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Lithium Therapy by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Lithium Therapy by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
• 12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

Lithium is a chemical element found in nature that is sometimes used in medicines to treat certain mental illnesses, such as bipolar disorder. Lithium can treat acute mania and help with longer-term mood stabilisation.It's also used in treating some types of depression and other types of mental illness.
Industry Insights

Due to the COVID-19 pandemic, the global Lithium Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Lithium Therapy market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Lithium Therapy landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Capsule accounting for % of the Lithium Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Online Sales segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Lithium Therapy include Bristol-Myers Squibb, Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, GlaxoSmithKline, Lundbeck, Allergan and Otsuka Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Lithium Therapy in 2021.

This report focuses on Lithium Therapy volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Lithium Therapy market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Lithium Therapy market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Capsule

Solution

Tablet

Others

Segment by Application

Online Sales

Offline Sales

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Bristol-Myers Squibb

Intellipharmaceutics

Pfizer

Eli Lilly

Astrazeneca

GlaxoSmithKline

Lundbeck

Allergan

Otsuka Pharmaceutical

Takeda

NHU Group

Shionogi

APOTEX

Kanghong Pharma

HUAHAI

Frequently Asked Questions

Which product segment grabbed the largest share in the Lithium Therapy market?

How is the competitive scenario of the Lithium Therapy market?

Which are the key factors aiding the Lithium Therapy market growth?

Which are the prominent players in the Lithium Therapy market?

Which region holds the maximum share in the Lithium Therapy market?

What will be the CAGR of the Lithium Therapy market during the forecast period?

Which application segment emerged as the leading segment in the Lithium Therapy market?

What key trends are likely to emerge in the Lithium Therapy market in the coming years?

What will be the Lithium Therapy market size by 2028?

Which company held the largest share in the Lithium Therapy market?